Directors of small public companies need to be nimble, to do more with decidedly less, and to shepherd companies against long odds for risk-embracing shareholders. The white-knuckle combination of ubiquitous enterprise risks and thin capitalization requires informed, frank, and focused boardroom dialogue, and reacting to shareholder activism is no exception.
Since many of the “best practices” developed for director-activist discourse are, unfortunately, one-size-fits-all, here are some discussion points specifically for directors of small companies to consider when faced with activist investors.
Ignore Shareholder Activists? Not an Option
Easily one of the biggest complaints of micro- and small-cap activist investors is that their outreach to officers and directors is often all but ignored. In fairness to the investors, many such advances receive conspicuously short shrift, and here’s why. Nearly one-third of exchange-listed companies have no equity research analyst coverage. Put differently, an enormous number of public companies toil in virtual obscurity.
Unlike larger companies that are covered by more than a dozen sell-side research analysts, present at national conferences numerous times a year, and have daily discourse with investors, there are literally thousands of public companies that have minimal contact with the Street. Many of these companies operate more like private companies (that happen to also have stock ticker symbols), and their reaction to “outsider meddling” is more like what you’d expect from a private company. Crickets.
Understanding why this regularly happens, though, is not to say it’s acceptable—far from it. Ignoring investors, whether they are supporters or detractors, is never a viable option for any public company, regardless of size. This is especially true with activist investors because they are not going to be the least bit dissuaded by silence. To the contrary, silence will often needlessly inflame activist settings. Regardless of how regularly they interface with the Street, small public companies need to have mechanisms in place for adequately addressing shareholder concerns.
Directors should consider routinely evaluating whether the “tone at the top” is conducive to the same both inside and outside of the boardroom.
There Is a Reason Activist Investors Have Shown up…
An outgrowth of the “private company” syndrome that can populate small public company boardrooms is a reflexive dismissiveness of anything that disgruntled shareholders have to say. The reality, though, is that activists tend to single-out particular companies for a reason. That is, in the history of capital markets, governance scrutiny tends to be inversely proportional to corporate performance. At a minimum, officers and directors should consider activist investors’ approaches as catalysts to scrutinize how and why their companies might be underperforming their peers (i.e., make lemonade out of lemons).
This is not to say, of course, that activist proposals are presumptively prudent. When you strip away the “activist” nomenclature, such investors likely aren’t any more “right” or “wrong” about what ails a particular company than any other capital markets participants. That said, activist investors typically don’t waste their time with well-performing companies, so boards of small public companies in particular should consider starting out in “listen” mode as opposed to “dismiss” mode.
The Importance of Objectivity
Even well-functioning, small public company boards can be more susceptible to the dangers of “groupthink” due to their characteristically smaller board sizes. Skeletal infrastructure also raises the likelihood of asymmetric information flow from management to the board. Taken together, boards of these companies must focus relentlessly on independent thinking, especially in the context of shareholder activism.
Since many small companies can’t afford to hire outside advisors to analyze typical activist proposals (e.g., share repurchases, cash dividends, compensation, M&A, spin-offs, board declassification, poison pill removal, add/change directors, business strategy overhaul, etc.), boards should, at a minimum, consider asking and answering a series of straightforward questions designed to objectively evaluate the company’s strategy for delivering long-term shareholder value, and its execution:
- Has the company articulated and adequately communicated its strategy for delivering long-term shareholder value? Put another way, if you randomly reached out to five of the company’s 20 largest outside investors, would they each be able to substantially recite the same? This question is important because some small public companies operate so close to the vest that even if they were executing well on their long-term strategy, it still might be a well-kept secret.
- Are the company’s income statement metrics (particularly those involving SG&A) consistent with its peers? This question is important because a hot button for micro- and small-cap activists is so-called “lifestyle companies”—companies with chronically stagnant stock prices and comparatively high salaries.
- What’s the average tenure of directors on the board? Reasonable people will differ, but if the average tenure is greater than 10 years, a refresh might be in order. And has the board’s nominating committee updated its composition “wish list” in the past 12 months to reflect the company’s current and prospective risks and opportunities?
- What is the stock ownership profile (i.e., shares owned, not options granted) of officers and directors compared to peers? This question is important because micro- and small-cap activist investors routinely take issue with officers and directors that have no “skin in the game.”
- Has the company delivered value to shareholders during the past one-, three-, and five-year periods that is equal to, or better than, its peers or other applicable benchmarks? If not, what are the root causes, and are the activist investors’ proposals aligned with those problems?
Activism is Here to Stay
Just saying the word “activist” in a room full of corporate directors is enough to raise collective blood pressures. Lost in the reaction, though, is the reality that activist investors are not all the same. Some activist investors are perceptive and experts when it comes to driving corporate change to benefit long-term shareholder value. Other activist investors opportunistically manipulate companies and the capital markets principally to capture near-term stock price movement.
Activism as a buy-side strategy is not only here to stay, but it’s on the rise in public companies of all sizes. Particularly for small public companies, diminished resources, small boards, thin capitalization, and myriad enterprise risks all make dealing with activist investors more challenging. But underperforming small companies also sometimes contribute to their tough sledding by treating dissatisfied shareholders with contempt as a matter of course.
Labels notwithstanding, each activist investor situation is novel, so the best boardroom approach is to listen and be objective.
A version of this post was originally published in Directorship magazine, July/August 2013.
Adam J. Epstein, is a former institutional investor, and now an advisor to CEOs and boards of pre-IPO and small-cap companies through his firm, Third Creek Advisors, LLC. He speaks monthly at private corporate events, and corporate governance and investor conferences, and has appeared internationally more than 100 times since 2012. Mr. Epstein is a key contributor to Nasdaq’s Amplify small-cap content initiative, and a mentor at the Nasdaq Entrepreneurial Center in San Francisco. He writes the “Entrepreneurial Governance” column for Directorship magazine, he’s the author of The Perfect Corporate Board: A Handbook for Mastering the Unique Challenges of Small-Cap Companies (New York: McGraw-Hill, 2012), and he’s a contributing author to The Handbook of Board Governance: A Comprehensive Guide for Public, Private and Not for Profit Board Members (New Jersey: Wiley, 2016). In June 2017, The Perfect Corporate Board was the #1 ranked corporate governance book on Amazon.com, and, in June 2016, The Handbook of Board Governance was the “#1 New Release” in corporate governance on Amazon.com. Connect with Adam on LinkedIn or learn more on his website.